Showing 15 posts of 26 posts found.


Transactions in the pharma sector: Through the EU merger review looking-glass

October 31, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mergers, mergers and acquisitions, pharma

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …

Pfizer to combine off-patent drug unit Upjohn with Mylan

July 30, 2019
Manufacturing and Production M&A, MA, Mylan, Pfizer, Upjohn, biosimilars, generics, mergers

Pfizer’s off-patent drug unit Upjohn is combining with Mylan to create a new global pharmaceutical company focused on the low-price …

$400 billion in healthcare M&A deals expected for 2019

January 7, 2019
Sales and Marketing Hong Kong, M&A, MA, biotech, deals pharma, law, mergers

The coming year is set to see mergers and acquisitions in the healthcare sector worth more than $400 billion, according …


Novartis denies potential split with Sandoz

November 15, 2018
Business Services, Manufacturing and Production Business, M&A, MA, Novartis, Sandoz, acquisition, mergers

Swiss newspaper Tages-Anzeiger has reported that Novartis is preparing for a split with long-term partner Sandoz. The two companies merged …

MSD logo

MSD to acquire Scottish firm IOmet Pharma

January 12, 2016
Research and Development, Sales and Marketing IOMet Pharma, MSD, Merck, Scotland, acquisitions, immuno-oncology, mergers, oncology

US pharma company MSD is to buy Edinburgh based IOMet Pharma to expand its existing R&D programme, exploring the development …

Shire and Baxalta reach $32 billion merger agreement

January 11, 2016
Manufacturing and Production, Sales and Marketing Baxalta, Shire, mergers, mergers and acquisitions

One of the industry’s longest-running M&A sagas has finally reached a conclusion, with Shire and Baxalta announcing a $32 billion …

AstraZeneca to buy majority share in Acerta Pharma

December 17, 2015
Sales and Marketing Acerta Pharma, AstraZeneca, acalabrutinib, acquisitions, mergers

Following several days of speculation, AstraZeneca has announced that it has agreed a deal to buy Acerta Pharma, a developer …


Mirror. Signal. Merger. How to deal with a pharma takeover

December 14, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing Deals, acquisition, buyouts, mergers, takeovers

So 2015 has been a record year for M&A in the pharma industry.The Financial Times has called this “the most …

AZ building

AstraZeneca in $5bn Acerta buyout talks

December 14, 2015
Sales and Marketing Acerta Pharma, AstraZeneca, acalabrutinib, acquisitions, blood cancer, buyout, chronic lymphocytic leukaemia, mergers, takeover

AstraZeneca has confirmed it is in negotiations to buy cancer drug developer Acerta Pharma BV for more than $5 billion …

Pfizer CEO Ian Read

Five benefits and challenges of the Pfizer/Allergan mega-merger

December 7, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Pfizer, acquisitions, mergers, takeovers

Pfizer was extremely keen to get the $160 billion deal done, but what is it getting out of the acquisition, …

Teva image

Teva strips $1 billion worth of assets to clear Allergan deal

December 4, 2015
Medical Communications, Sales and Marketing Allergan, Teva, acquisitions, divestments, mergers

Teva Pharmaceuticals is thought to be in the process of stripping nearly $1 billion worth of assets to address antitrust …


Merck KGaA completes $17bn Sigma-Aldrich acquisition

November 18, 2015
Manufacturing and Production, Sales and Marketing M&A Sigma Aldridge, Merck, acquisitions, mergers

Merck KGaA has announced the completion of its $17 billion acquisition of Sigma-Aldrich, having cleared the final regulatory hurdle and …

LEO logo

LEO Pharma buys dermatology portfolio from Astellas

November 12, 2015
Sales and Marketing Astellas, LEO Pharma, acquisitions, dermatology, mergers

LEO Pharma, the speciality dermatology firm, is looking to expand its presence in the therapy area by buying Astellas’ portfolio …

astrazeneca image

AstraZeneca acquires ZS Pharma for $2.7bn, announces Q3 results

November 6, 2015
Medical Communications AstraZeneca, M&A, MA, ZS Pharma, ZS-9, acquisitions, financial results, hyperkalaemia, mergers

AstraZeneca has announced its acquisition of ZS Pharma for an all-cash total of $2.7 billion. In the latest mega-money deal …

Latest content